Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 82.28% | -3.73% | |||
| Gross Profit | -82.28% | 3.73% | |||
| SG&A Expenses | -12.08% | -11.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.92% | -9.70% | |||
| Operating Income | -14.92% | 9.70% | |||
| Income Before Tax | -15.79% | 8.25% | |||
| Income Tax Expenses | -105.31% | 83.49% | |||
| Earnings from Continuing Operations | -14.88% | 3.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.88% | 3.75% | |||
| EBIT | -14.92% | 9.70% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -11.57% | 5.24% | |||
| Normalized Basic EPS | -12.44% | 9.67% | |||
| EPS Diluted | -11.57% | 5.24% | |||
| Normalized Diluted EPS | -12.44% | 9.67% | |||
| Average Basic Shares Outstanding | 2.97% | 1.58% | |||
| Average Diluted Shares Outstanding | 2.97% | 1.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||